期刊文献+

初发急性白血病初期化疗的疗效预测 被引量:2

Early Prediction of Efficaciousness after First Course of Chemotherapy in De Novo Acute Leukemia
下载PDF
导出
摘要 急性白血病要获完全缓解 (CR)必须经过化疗后的骨髓增生抑制期。在此期间外周血白细计数必然急剧减少。为了观察急性白血病化疗后白细胞 (WBC)计数与化疗疗效之间的关系 ,对 80例初治急性白血病患者在诱导化疗第 1疗程后WBC计数与疗效关系进行了分析。根据化疗后白细胞数的最低值分为 3组 :≤ 0 .4× 10 9/L组 ;(0 .4 - 0 .9)× 10 9/L组 ;>0 .9× 10 9/L组。结果表明 :初治急性白血病化疗第 1疗程后 ,WBC计数≤ 0 .4× 10 9/L的急性白血病CR率 6 0 % ,总有效率 90 % ;WBC计数在 (0 .4 - 0 .9)× 10 9/L的急性白血病CR率 5 5 .6 % ,总有效率 92 .6 % ;WBC计数 >0 .9× 10 9/L的急性白血病CR率 2 7.3% ,总有效率 6 6 .7%。白细胞≤ 0 .4× 10 9/L组 ,(0 .4 - 0 .9)× 10 9/L组与 >0 .9× 10 9/L组第 1疗程化疗有效率有显著性差异 (P <0 .0 1)。而白细胞≤ 0 .4× 10 9/L组与白细胞 (0 .4 - 0 .9)× 10 9/L组无明显差异。结论 :初发急性白血病第 1疗程化疗后白细胞计数可作为急性白血病化疗的一个预测指标。 To achieve the complete remission (CR), acute leukemia (AL) patient must get through the period of myloid ablation after chemotherapy that the white blood cell (WBC) count in peripheral blood decreases rapidly. To observe the relationship of WBC count with therapeutic effectiveness after chemotherapy in previously untreated AL, eighty cases of previously untreated acute leukemia who took the first induction chemotherapy course were analyzed. Blood routine was carried out 2 to 3 times every week while the bone marrow pictures on 12th and 20th day after chemothrapy were observed. 80 patients were divided into 3 groups based on the lowest value of WBC count after chemotherapy: ≤0.4×10 9/L group, (0.4-0.9)×10 9/L group and >0.9×10 9/L group. The results showed that the complete remission rates after the first course of chemotherapy were 60 vs 55.6 vs 27.3% respectively in the three groups which WBC counts were ≤0.4×10 9/L, (0.4-0.9)×10 9/L and >0.9×10 9/L. The total efficaciousness rates were 90 vs 92.6 vs 66.7 respectively in the three groups. The efficaciousness rate of the first two groups significantly differed from the third group ( P <0.01). However, no significant difference was shown between the first and second groups. It is concluded that the leukocyte count after the first course of chemotherapy may be an early indicator to predict the efficaciousness of chemotherapy.
出处 《中国实验血液学杂志》 CAS CSCD 2004年第1期105-107,共3页 Journal of Experimental Hematology
关键词 急性白血病 诱导化疗 白细胞计数 acute leukemia induction chemotherapy white blood cell count
  • 相关文献

参考文献5

二级参考文献15

  • 1谭元菊.78例恶性血液病医院感染分析[J].临床血液学杂志,1994,7(2):65-67. 被引量:38
  • 2熊金元,瞿群华,张新华,付涛,谢红.201例急性白血病死亡分析及经验教训[J].临床血液学杂志,1996,9(3):118-119. 被引量:13
  • 3宫笑微,杨英男,胡业萍,张慧彬.大剂量谷维素防治急性白血病口腔感染临床观察[J].白血病,1996,5(4):223-224. 被引量:4
  • 4全国白血病化学治疗讨论会.急性白血病疗效标准[J].中华血液学杂志,1988,9(3):183-183. 被引量:49
  • 5Finnish Leukaemia Group. Long-term survival in acute lymphoblastic leukaemia inadults: a prospective study of 51 patients. Eur J Haematol, 1992,48:75~82 被引量:1
  • 6Ho T C, Tefferi A, Su J G, et al. Acute lymphocytic leukemia in adults: Aretrospective study and analysis of current management options. Mayo Clin Pro, 1994,69:937~948 被引量:1
  • 7Bennett J M, Andersent J W,Cassileth P. Long term survival in acute myeloidleukemia: the Eastern Cooperative Oncology Group(ECOG) experience. Leuk Res, 1991,15:223~227 被引量:1
  • 8Childhood ALL Collaborative Group. Duration and intensity of maintenancechemotherapy in acute lymphoblastic leukaemia: overview of 42 trials involving 12000randomised children. Lancet, 1996, 347:1783~1788 被引量:1
  • 9Swansbury G T, Lawler S D, Alimena G, et al. Long-term survival in acutemyelogenous leukemia: A second follow-up of the Fourth International Workshop onchromosomes in leukemia. Cancer Genet Cytogenet, 1994,73:1~7 被引量:1
  • 10Bandini G, Zuffa E, Rosti G, et al.Long-term outcome of adults with acutemyelogenous leukemia: results of a prospective, randomized study of chemotherapy with aminimal follow-up of 7 years. Br J Haematol, 1991, 77:486~490 被引量:1

共引文献25

同被引文献9

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部